Skip To Main Content
Ryan Cross on Muck Rack

Ryan Cross

Verified
Boston, Cambridge
As seen in: Endpoints News, Boston.com, MDPI, Scientific American, ACS Publications, Chemical & Engineering News (C&EN), MIT Technology Review, The Boston Globe, Science Magazine, EIN News, Genetic Literacy Project and
Senior Science Correspondent for @Endpts covering biotech, drug discovery, gene editing, RNA, and more. Formerly at Boston Globe and C&EN. Signal: RyanCross.25

Get in touch with Ryan

Contact Ryan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Ryan Cross’s Journalist Portfolio

See all →
CRISPR's breakthrough problem

CRISPR's breakthrough problem

Serving The Chemical, Life Sciences & Laboratory Worlds

View article →
This $25,000 physical has found some 'serious' health problems. Others say it has serious problem...

This $25,000 physical has found some 'serious' health problems. Others say it has serious problem...

Personal DNA sequencing once promised to up the ante for individualized medicine. Perhaps no one believed tha…

View article →
New 3D scanning campaign will reveal 20,000 animals in stunning detail

New 3D scanning campaign will reveal 20,000 animals in stunning detail

Known as the "Fish Guy," Adam Summers earned his moniker for an odd hobby turned academic obsession: giving d…

View article →
Elderly chimps may get Alzheimer's, renewing interest in studying these animals

Elderly chimps may get Alzheimer's, renewing interest in studying these animals

Researchers have discovered tell-tale signs of Alzheimer's disease in 20 elderly chimpanzee brains, rekindlin…

View article →
Memory-enhancing drug reverses effects of traumatic brain injury in mice

Memory-enhancing drug reverses effects of traumatic brain injury in mice

Whether caused by a car accident that slams your head into the dashboard or repeated blows to your cranium fr…

View article →
'Scientific wellness' study-and a famed biologist's spinoff company-divide researchers

'Scientific wellness' study-and a famed biologist's spinoff company-divide researchers

Leroy Hood knows a thing or two about disruptive technologies. One of biology's living legends, the now 78-ye…

View article →

Articles

China deaths reignite debate about using viruses to deliver CRISPR therapies

|
By Ryan Cross Verified
| Endpoints News Verified
China deaths reignite debate about using viruses to deliver CRISPR therapies The deaths of two children who received CRISPR therapies in China have rattled scientists who work on similar genetic medicines in the US, adding new … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Open in Who Shared Issue with article?

Exclusive: Typewriter raises $56M for jumping-gene tech, in vivo CAR-T

|
By Ryan Cross Verified
| Endpoints News Verified
Typewriter CEO Matthew Stanton (L) and CSO Leanne Peiser Exclusive: Typewriter raises $56M for jumping-gene tech, in vivo CAR-T Moving pieces of genetic code commonly called “jumping genes” could give scientists a long-sought way to transplant full genes into the human … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Open in Who Shared Issue with article?

ARPA-H awards $125M for manufacturing custom RNA therapies on demand

|
By Ryan Cross Verified
| Endpoints News Verified
ARPA-H awards $125M for manufacturing custom RNA therapies on demand The dream of making personalized genetic medicines at a moment’s notice just got a major infusion of funding from the federal government. Five groups were … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Open in Who Shared Issue with article?
See all 938 licensed articles (1,044 Total)